0
Deep & Emerging Tech·July 17, 2026·1 min read

Mollie doubles down on Europe with €350m expansion plan: ‘Superapp is a convoluted word’

Share

A €350m push focused on Europe and a rejection of the “superapp” label says the payments land grab is now about depth in regulated regions, not copying Asian playbooks. If you’re building in fintech, assume more specialized, regionally dominant rails rather than one global UX layer.

Deep & Emerging Tech

Kalshi is offering wagers on the outcomes of late-stage clinical drug trials and regulatory decisions, launching a pilot of 13 new biotech contracts

Prediction markets on late-stage trials and FDA decisions turn biotech milestones into tradable signals—drug developers and funds now get a real-time, crowd-priced read on regulatory odds. Operators in pharma and biotech should expect their timelines and disclosures to be interpreted—and front-run—through this new market lens.